Horm Metab Res 2012; 44(07): 533-538
DOI: 10.1055/s-0032-1304578
Humans, Clinical
© Georg Thieme Verlag KG Stuttgart · New York

Sexual Dimorphism on Growth Hormone Secretion after Oral Glucose Administration

E. Outeiriño-Blanco
1   Department of Endocrinology, University Hospital A Coruña, La Coruña, Spain
,
J. Garcia-Buela
2    Department of Laboratory, University Hospital A Coruña, La Coruña, Spain
,
S. Sangiao-Alvarellos
3    Department of Investigation University Hospital A Coruña, La Coruña, Spain
4   Department of Medicine University of A Coruña , La Coruña, Spain
,
I. Brandón
3    Department of Investigation University Hospital A Coruña, La Coruña, Spain
,
L. Pena
3    Department of Investigation University Hospital A Coruña, La Coruña, Spain
,
S. Pertega-Diaz
5   Clinical Epidemiology and Biostatistics Unit, University Hospital A Coruña, La Coruña, Spain
,
T. Martinez
1   Department of Endocrinology, University Hospital A Coruña, La Coruña, Spain
,
F. Cordido
1   Department of Endocrinology, University Hospital A Coruña, La Coruña, Spain
3    Department of Investigation University Hospital A Coruña, La Coruña, Spain
4   Department of Medicine University of A Coruña , La Coruña, Spain
› Author Affiliations
Further Information

Publication History

received 21 September 2011

accepted 19 January 2012

Publication Date:
16 February 2012 (online)

Abstract

Sexual dimorphism of GH secretion is unclear in humans. There is evidence that oral glucose (OG) administration initially decreases and subsequently stimulates GH secretion. Our aim was to study fasting GH concentrations and their response to OG administration in obese and healthy women and men, in order to elucidate the mechanism of sexual dimorphism of GH secretion and the possible contribution of ghrelin. We selected 33 women and 11 men as obese and healthy subjects. After an overnight fast, 75 g of oral glucose were administered; glucose, insulin, ghrelin, and PYY1–36 were obtained at baseline and during 300 min. Fasting GH (μg/l) was higher in women than men; 1.3±0.3 vs. 0.2±0.1, p=0.009, for women and men, respectively. The area under the curve between 0 and 150 min (AUC) of GH (μg/l · min) was higher in women than men; 98.2±25.9 vs. 41.5±28.6, p=0.002, for women and men, respectively. The AUC of total ghrelin (pg/ml · min, mean±SEM) between 0 and 150 min was borderline and significantly higher in women than men; 128 562.3±8 335.9 vs. 98 839.1±7 668.6, p=0.069, for women and men, respectively. Several initial time points were higher in women than men. Glucose, insulin, and PYY1–36 were similar in women and men after OG. There were significant correlations between indices of post-oral glucose GH and ghrelin secretion. Fasting and initial GH secretion is higher in women than men, in contrast to peak and late GH secretion, which is similar in both cases. Sexual dimorphism in the regulation of GH secretion probably involves ghrelin.

 
  • References

  • 1 Gatford KL, Egan AR, Clarke IJ, Owens PC. Sexual dimorphism of the somatotrophic axis. J Endocrinol 1998; 157: 373-389
  • 2 Jaffe CA, Ocampo-Lim B, Guo W, Krueger K, Sughara I, DeMott-Friberg R, Bermann M, Barkan AL. Regulatory mechanisms of growth hormone secretion are sexually dimorphic. J Clin Invest 1998; 102: 153-164
  • 3 Jessup SK, Dimaraki EV, Symons KV, Barkan AL. Sexual dimorphism of growth hormone (GH) regulation in humans: endogenous GH-releasing hormone maintains basal GH in women but not in men. J Clin Endocrinol Metab 2003; 88: 4776-4780
  • 4 Veldhuis JD, Roelfsema F, Keenan DM, Pincus S. Gender, Age, body mass index, and IGF-I individually and jointly determine distinct GH dynamics: Analyses in one hundred healthy adults. J Clin Endocrinol Metab 2011; 96: 115-121
  • 5 Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 999; 402: 656-660
  • 6 Alvarez-Castro P, Isidro ML, Garcia-Buela J, Leal-Cerro A, Broglio F, Tassone F, Ghigo E, Dieguez C, Casanueva FF, Cordido F. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients. Clin Endocrinol (Oxf) 2004; 61: 250-255
  • 7 Alaioubi B, Mann K, Petersenn S. Diagnosis of growth hormone deficiency in adults: provocative testing with GHRP6 in comparison to the insulin tolerance test. Horm Metab Res 2009; 41: 238-243
  • 8 Lanfranco F, Motta G, Baldi M, Gasco V, Grottoli S, Benso A, Broglio F, Ghigo E. Ghrelin and anterior pituitary function. Front Horm Res 2010; 38: 206-211
  • 9 Perez-Fontan M, Cordido F, Rodriguez-Carmona A, Garcia-Naveiro R, Isidro ML, Villaverde P, Garcia-Buela J. Acute plasma ghrelin and leptin responses to oral feeding or intraperitoneal hypertonic glucose-based dialysate in patients with chronic renal failure. Kidney Int 2005; 68: 2877-2885
  • 10 Misra M, Miller KK, Kuo K, Griffin K, Stewart K, Hunter E, herzog DB, Klibanski A. Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 2005; 289: E347-E356
  • 11 Nass R, Farhy LS, Liu J, Prudom CE, Johnson ML, Veldhuis J, Pezzoli SS, Oliveri MC, Gaylinn BD, Geysen HM, Thorner MO. Evidence for acyl-ghrelin modulation of growth hormone release in the fed state. J Clin Endocrinol Metab 2008; 93: 1988-1994
  • 12 Outeirino-Blanco E, Garcia-Buela J, Sangiao-Alvarellos S, Pertega-Diaz S, Martinez-Ramonde T, Cordido F. Growth Hormone, Ghrelin and Peptide YY Secretion after Oral Glucose Administration in Healthy and Obese Women. Horm Metab Res 2011; 43: 580-586
  • 13 Ingelsson E, Larson MG, Yin X, Wang TJ, Meigs JB, Lipinska I, Benjamin EJ, Keaney JF, Vasan RS. Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community-based sample. J Clin Endocrinol Metab 2008; 93: 3149-3157
  • 14 Barkan AL, Dimaraki EV, Jessup SK, Symons KV, Ermolenko M, Jaffe CA. Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. J Clin Endocrinol Metab 2003; 88: 2180-2184
  • 15 Resmini E, Andraghetti G, Rebora A, Cordera R, Vera L, Giusti M, Minuto F, Ferone D. Leptin, ghrelin, and adiponectin evaluation in transsexual subjects during hormonal treatments. J Androl 2008; 29: 580-585
  • 16 Lloyd B, Ravi P, Mendes N, Klibanski A, Misra M. Peptide YY levels across pubertal stages and associations with growth hormone. J Clin Endocrinol Metab 2010; 95: 2957-2962
  • 17 Grottoli S, Procopio M, Maccario M, Zini M, Oleandr SE, Tassone F, Valcavi R, Ghigo E. In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion. J Clin Endocrinol Metab 1997; 82: 2261-2265
  • 18 Shiiya T, Nakazato M, Mizuta M, date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K, Matsukura S. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002; 87: 240-244
  • 19 Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 2005; 85: 495-522
  • 20 Benedini S, Codella R, Caumo A, Marangoni F, Luzi L. Different circulating ghrelin responses to isoglucidic snack food in healthy individuals. Horm Metab Res 2011; 43: 135-140
  • 21 Cordido F, Garcia-Buela J, Sangiao-Alvarellos S, Martinez T, Vidal O. The decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors. Mediators Inflamm 2010; 2010: 434562
  • 22 Sangiao-Alvarellos S, Vazquez MJ, Varela L, Nogueiras R, Saha AK, Cordido F, Lopez M, Dieguez C. Central ghrelin regulates peripheral lipid metabolism in a growth hormone-independent fashion. Endocrinology 2009; 150: 4562-4574
  • 23 Sangiao-Alvarellos S, Varela L, Vazquez MJ, Da Boit K, Saha AK, Cordido F, Dieguez C, Lopez M. Influence of Ghrelin and growth hormone deficiency on AMP-activated protein kinase and hypothalamic lipid metabolism. J Neuroendocrinol 2010; 22: 543-556
  • 24 Sangiao-Alvarellos S, Helmling S, Vazquez MJ, Klussmann S, Cordido F. Ghrelin neutralization during fasting-refeeding cycle impairs the recuperation of body weight and alters hepatic energy metabolism. Mol Cell Endocrinol 2011; 335: 177-188
  • 25 Osterstock G, Escobar P, Mitutsova V, Gouty-Colomer LA, Fontanaud P, Molino F, Fehrentz JA, Carmignac D, Martinez J, Guerineau NC, Robinson IC, Mollard P, Mery PF. Ghrelin stimulation of growth hormone-releasing hormone neurons is direct in the arcuate nucleus. PLoS ONE 2010; 5: e9159
  • 26 Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell FE, Clasey JL, Heymsfield SB, Bach MA, Vance ML, Thorner MO. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med 2008; 149: 601-611
  • 27 Pantel J, Legendre M, Nivot S, Morisset S, Vie-Luton MP, le Bouc Y, Epelbaum J, Amselem S. Recessive isolated growth hormone deficiency and mutations in the ghrelin receptor. J Clin Endocrinol Metab 2009; 94: 4334-4341
  • 28 Zhao TJ, Liang G, Li RL, Xie X, Sleeman MW, Murphy AJ, Valenzuela DM, Yancopoulos GD, Goldstein JL, Brown MS. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proc Natl Acad Sci USA 2010; 107: 7467-7472
  • 29 Ji XS, Chen SL, Jiang YL, Xu TJ, Yang JF, Tian YS. Growth differences and differential expression analysis of pituitary adenylate cyclase activating polypeptide (PACAP) and growth hormone-releasing hormone (GHRH) between the sexes in half-smooth tongue sole Cynoglossus semilaevis. Gen Comp Endocrinol 2011; 170: 99-109
  • 30 Diz-Lois MT, Garcia-Buela J, Suarez F, Sangiao-Alvarellos S, Vidal O, Cordido F. Fasting and postprandial plasma ghrelin levels are decreased in patients with liver failure previous to liver transplantation. Endocrine 2009; 35: 467-476
  • 31 Diz-Lois MT, Garcia-Buela J, Suarez F, Sangiao-Alvarellos S, Vidal O, Cordido F. Altered fasting and postprandial plasma ghrelin levels in patients with liver failure are normalized after liver transplantation. Eur J Endocrinol 2010; 163: 609-616
  • 32 Rodriguez-Carmona A, Perez Fontan M, Cordido F, Garcia Falcon T, Garcia-Buela J. Hyperleptinemia is not correlated with markers of protein malnutrition in chronic renal failure. A cross-sectional study in predialysis, peritoneal dialysis and hemodialysis patients. Nephron 2000; 86: 274-280
  • 33 Peino R, Fernandez Alvarez J, Penalva A, Considine RV, Rodriguez-Segade S, Rodriguez-Garcia J, Cordido F, Casanueva FF, Dieguez C. Acute changes in free-fatty acids (FFA) do not alter serum leptin levels. J Endocrinol Invest 1998; 21: 526-530
  • 34 Saad MF, Damani S, Gingerich RL, Riad-Gabriel MG, Khan A, Boyadjian R, Jinagouda SD, el-Tawil K, Rude RK, Kamdar V. Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab 1997; 82: 579-584
  • 35 Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 1997; 82: 1293-1300
  • 36 Guerra B, Fuentes T, Delgado-Guerra S, Guadalupe-Grau A, Olmedillas H, Santana A, Ponce-Gonzalez JG, Dorado C, Calbet JA. Gender dimorphism in skeletal muscle leptin receptors, serum leptin and insulin sensitivity. PLoS ONE 2008; 3: e3466
  • 37 Alvarez-Castro P, Sangiao-Alvarellos S, Brandon-Sanda I, Cordido F. Endocrine function in obesity. Endocrinol Nutr 2011; 58: 422-432
  • 38 Ondrak KS, McMurray RG, Hackney AC, Harrell JS. Interrelationships among changes in leptin, insulin, cortisol and growth hormone and weight status in youth. J Clin Res Pediatr Endocrinol 2011; 3: 22-28
  • 39 Liu Y, Zhong Y, Pei J, Zhu Y, Hu Y, Chi S, Kaye AD. Inhibitory effect of leptin on growth hormone secretion of GH3 cells: involvement of cell proliferation, apoptosis and intracellular free Ca2. Cytokine 2009; 46: 245-250
  • 40 Roubenoff R, Rall LC, Veldhuis JD, Kehayias JJ, Rosen C, Nicolson M, Lundgren N, Reichlin S. The relationship between growth hormone kinetics and sarcopenia in postmenopausal women: the role of fat mass and leptin. J Clin Endocrinol Metab 1998; 83: 1502-1506
  • 41 Roemmler J, Otto B, Arafat AM, Bidlingmaier M, Schopohl J. Influence of pegvisomant on serum ghrelin and leptin levels in acromegalic patients. Eur J Endocrinol 2010; 163: 727-734
  • 42 Roemmler J, Gockel A, Otto B, Bidlingmaier M, Schopohl J. Effects on metabolic variables after 12-month treatment with a new once-a-week sustained-release recombinant growth hormone (GH: LB03002) in patients with GH deficiency (GHD). Clin Endocrinol (Oxf) 2012; 76: 88-95
  • 43 Yamashita S, Melmed S. Insulin regulation of rat growth hormone gene transcription. J Clin Invest 1986; 78: 1008-1014
  • 44 Clasey JL, Weltman A, Patrie J, Weltman JY, Pezzoli S, Bouchard C, Thorner MO, Hartman ML. Abdominal visceral fat and fasting insulin are important predictors of 24-h GH release independent of age, gender, and other physiological factors. J Clin Endocrinol Metab 2001; 86: 3845-3852
  • 45 McLaughlin T, Abbasi F, Lamendola C, Frayo RS, Cummings DE. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J Clin Endocrinol Metab 2004; 89: 1630-1635
  • 46 Hotta M, Ohwada R, Katakami H, Shibasaki T, Hizuta N, Takano K. Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa. J Clin Endocrinol Metab 2004; 89: 5707-5712
  • 47 Blatnik M, Soderstrom CI. A practical guide for the stabilization of acylghrelin in human blood collections. Clin Endocrinol (Oxf) 2011; 74: 325-331